Idarucizumab for dabigatran reversal

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Pollack, Charles V. (VerfasserIn) , Steiner, Thorsten (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 6 August 2015
In: The New England journal of medicine
Year: 2015, Jahrgang: 373, Heft: 6, Pages: 511-520
ISSN:1533-4406
DOI:10.1056/NEJMoa1502000
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1056/NEJMoa1502000
Volltext
Verfasserangaben:Charles V. Pollack, Paul A. Reilly, John Eikelboom, Stephan Glund, Peter Verhamme, Richard A. Bernstein, Robert Dubiel, Menno V. Huisman, Elaine M. Hylek, Pieter W. Kamphuisen, Jörg Kreuzer, Jerrold H. Levy, Frank W. Sellke, Joachim Stangier, Thorsten Steiner, Bushi Wang, Chak‑Wah Kam and Jeffrey I. Weitz

MARC

LEADER 00000caa a2200000 c 4500
001 1551896699
003 DE-627
005 20230426141208.0
007 cr uuu---uuuuu
008 170118s2015 xx |||||o 00| ||eng c
024 7 |a 10.1056/NEJMoa1502000  |2 doi 
035 |a (DE-627)1551896699 
035 |a (DE-576)481896694 
035 |a (DE-599)BSZ481896694 
035 |a (OCoLC)1340955696 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Pollack, Charles V.  |e VerfasserIn  |0 (DE-588)140620974  |0 (DE-627)703735160  |0 (DE-576)319144860  |4 aut 
245 1 0 |a Idarucizumab for dabigatran reversal  |c Charles V. Pollack, Paul A. Reilly, John Eikelboom, Stephan Glund, Peter Verhamme, Richard A. Bernstein, Robert Dubiel, Menno V. Huisman, Elaine M. Hylek, Pieter W. Kamphuisen, Jörg Kreuzer, Jerrold H. Levy, Frank W. Sellke, Joachim Stangier, Thorsten Steiner, Bushi Wang, Chak‑Wah Kam and Jeffrey I. Weitz 
264 1 |c 6 August 2015 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 18.01.2017 
700 1 |a Steiner, Thorsten  |d 1961-  |e VerfasserIn  |0 (DE-588)118107623  |0 (DE-627)079247407  |0 (DE-576)291718779  |4 aut 
773 0 8 |i Enthalten in  |t The New England journal of medicine  |d Waltham, Mass. : MMS, 1928  |g 373(2015), 6, Seite 511-520  |h Online-Ressource  |w (DE-627)266889484  |w (DE-600)1468837-2  |w (DE-576)075962454  |x 1533-4406  |7 nnas  |a Idarucizumab for dabigatran reversal 
773 1 8 |g volume:373  |g year:2015  |g number:6  |g pages:511-520  |g extent:10  |a Idarucizumab for dabigatran reversal 
856 4 0 |u http://dx.doi.org/10.1056/NEJMoa1502000  |x Verlag  |x Resolving-System  |3 Volltext 
951 |a AR 
992 |a 20170118 
993 |a Article 
994 |a 2015 
998 |g 118107623  |a Steiner, Thorsten  |m 118107623:Steiner, Thorsten  |d 910000  |d 911100  |e 910000PS118107623  |e 911100PS118107623  |k 0/910000/  |k 1/910000/911100/  |p 15 
999 |a KXP-PPN1551896699  |e 2950769756 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Charles V. Pollack, Paul A. Reilly, John Eikelboom, Stephan Glund, Peter Verhamme, Richard A. Bernstein, Robert Dubiel, Menno V. Huisman, Elaine M. Hylek, Pieter W. Kamphuisen, Jörg Kreuzer, Jerrold H. Levy, Frank W. Sellke, Joachim Stangier, Thorsten Steiner, Bushi Wang, Chak‑Wah Kam and Jeffrey I. Weitz"]},"origin":[{"dateIssuedKey":"2015","dateIssuedDisp":"6 August 2015"}],"id":{"eki":["1551896699"],"doi":["10.1056/NEJMoa1502000"]},"physDesc":[{"extent":"10 S."}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["266889484"],"zdb":["1468837-2"],"issn":["1533-4406"]},"origin":[{"publisher":"MMS ; MMS","dateIssuedKey":"1928","dateIssuedDisp":"1928-","publisherPlace":"Waltham, Mass. ; Boston, Mass."}],"name":{"displayForm":["Massachusetts Medical Society"]},"titleAlt":[{"title":"NEJM"}],"part":{"year":"2015","issue":"6","pages":"511-520","text":"373(2015), 6, Seite 511-520","volume":"373","extent":"10"},"pubHistory":["198.1928 -"],"recId":"266889484","language":["eng"],"corporate":[{"role":"isb","roleDisplay":"Herausgebendes Organ","display":"Massachusetts Medical Society"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Idarucizumab for dabigatran reversalThe New England journal of medicine","note":["Gesehen am 04.08.25"],"title":[{"title":"The New England journal of medicine","subtitle":"NEJM","title_sort":"New England journal of medicine"}]}],"person":[{"family":"Pollack","given":"Charles V.","roleDisplay":"VerfasserIn","display":"Pollack, Charles V.","role":"aut"},{"given":"Thorsten","family":"Steiner","role":"aut","display":"Steiner, Thorsten","roleDisplay":"VerfasserIn"}],"title":[{"title":"Idarucizumab for dabigatran reversal","title_sort":"Idarucizumab for dabigatran reversal"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 18.01.2017"],"recId":"1551896699","language":["eng"]} 
SRT |a POLLACKCHAIDARUCIZUM6201